Vimarsana
Biggest News Aggregation in the World

Ivan Horak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ivan Horak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ivan Horak Today - Breaking & Trending Today

PRODUCTION: Tereza Nvotová Preps Slovak/Czech/Polish Drama Father - Vimarsana News

PRODUCTION: Tereza Nvotová Preps Slovak/Czech/Polish Drama Father

BRATISLAVA: The succesful Slovak director Tereza Nvotová is currently in preproduction with her third feature film Father / Otec. The drama based on t...

Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy Shows - Vimarsana News

Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy Shows

78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X allogeneic CAR-T therapySafety data...

Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma, Business News - Vimarsana News

Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma, Business News

Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma GlobeNewswire June 16, 2023 78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X allogeneic CAR-T therapySafety data encouraging with no graft-versus-host-disease and no neurotoxicityUpdated data highlighted in podium presentation at the 17th...

Tessa Therapeutics Ltd: Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023 - Vimarsana News

Tessa Therapeutics Ltd: Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023

Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022SINGAPORE, Jan. 03, 2023 (Tessa), a clinical-stage cell therapy company developing

Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023 - Vimarsana News

Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023

Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023 Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022 GlobeNewswire January 03, 2023 SINGAPORE, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments...